Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 2, 2006, Pages

  Barton, Elisabeth R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Eccentric contractions; Extracellular signal regulated kinase 1 2; Muscular dystrophy

Indexed keywords

DYSTROPHIN; GAMMA SARCOGLYCAN; GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SARCOGLYCAN; UNCLASSIFIED DRUG; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; ISOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ECCENTRIC MUSCLE CONTRACTION; ENZYME PHOSPHORYLATION; EXTENSOR DIGITORUM LONGUS MUSCLE; IMMUNOPRECIPITATION; LIMB GIRDLE MUSCULAR DYSTROPHY; MECHANICAL STRESS; MECHANOTRANSDUCTION; MOUSE; MUSCLE INJURY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; CYTOLOGY; ENZYME ACTIVATION; GENETICS; METABOLISM; MOUSE MUTANT; MUSCLE CONTRACTION; PHOSPHORYLATION; PHYSIOLOGY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALIA; MURINAE;

ANIMALS; DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX; ENZYME ACTIVATION; MECHANOTRANSDUCTION, CELLULAR; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN ISOFORMS; SARCOGLYCANS;

EID: 33644868707     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00192.2005     Document Type: Article

References (47)

1. Aronson D, Violan MA, Dufresne SD, Zangen D, Fielding RA, and Goodyear LJ. Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle. J Clin Invest 99: 1251-1257, 1997.
2. Aronson D, Wojtaszewski JF, Thorell A, Nygren J, Zangen D, Richter EA, Ljungqvist O, Fielding RA, and Goodyear LJ. Extracellular-regulated protein kinase cascades are activated in response to injury in human skeletal muscle. Am J Physiol Cell Physiol 275: C555-C561, 1998.
3. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, and Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95: 15603-15607, 1998.
4. Bonnemann CG and Finkel RS. Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies. Semin Pediatr Neurol 9: 81-99, 2002.
5. Bonnemann CG, Thompson TG, van der Ven PF, Goebel HH, Warlo I, Vollmers B, Reimann J, Herms J, Gautel M, Takada F, Beggs AH, Furst DO, Kunkel LM, Hanefeld F, and Schroder R. Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle. J Neurol Sci 206: 71-78, 2003.
6. 2-terminal kinase activity in human skeletal muscle. J Appl Physiol 87: 1668-1673, 1999.
7. 2-terminal kinase and p38 activities in human skeletal muscle. J Physiol 526: 663-669, 2000.
8. 2-terminal kinase activity and p38 phosphorylation in rat skeletal muscle. Am J Physiol Cell Physiol 280: C352-C358, 2001.
9. Boudreau NJ and Jones PL. Extracellular matrix and integrin signalling: the shape of things to come. Biochem J 339: 481-488, 1999.
10. Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, and Kaufman SJ. Enhanced expression of the α7β1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol 152: 1207-1218, 2001.
11. Campbell KP. Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell 80: 675-679, 1995.
12. Cox GA, Sunada Y, Campbell KP, and Chamberlain JS. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet 8: 333-339, 1994.
13. Crosbie RH, Barresi R, and Campbell KP. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J 16: 1786-1791, 2002.
14. Disatnik MH and Rando TA. Integrin-mediated muscle cell spreading. The role of protein kinase C in outside-in and inside-out signaling and evidence of integrin cross-talk. J Biol Chem 274: 32486-32492, 1999.
15. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, Stull JT, and Sanes JR. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1: 215-220, 1999.
16. Greenberg DS, Sunada Y, Campbell KP, Yaffe D, and Nudel U. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat Genet 8: 340-344, 1994.
17. Griffin MA, Feng H, Tewari M, Acosta P, Kawana M, Sweeney HL, and Discher DE. γ-Sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway activation but does not affect adhesion. J Cell Sci 118: 1405-1416, 2005.
18. Guyon JR, Kudryashova E, Potts A, Dalkilic I, Brosius MA, Thompson TG, Beckmann JS, Kunkel LM, and Spencer MJ. Calpain 3 cleaves filamin C and regulates its ability to interact with γ- and δ-sarcoglycans. Muscle Nerve 28: 472-483, 2003.
19. Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, and McNally EM. Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci USA 96: 10723-10728, 1999.
20. Hack AA, Groh ME, and McNally EM. Sarcoglycans in muscular dystrophy. Microsc Res Tech 48: 167-180, 2000.
21. Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, and McNally EM. γ-Sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142: 1279-1287, 1998.
22. Hayashi T, Hirshman MF, Dufresne SD, and Goodyear LJ. Skeletal muscle contractile activity in vitro stimulates mitogen-activated protein kinase signaling. Am J Physiol Cell Physiol 277: C701-C707, 1999.
23. Heydemann A, Huber JM, Kakkar R, Wheeler MT, and McNally EM. Functional nitric oxide synthase mislocalization in cardiomyopathy. J Mol Cell Cardiol 36: 213-223, 2004.
24. Hornberger TA, Stuppard R, Conley KE, Fedele MJ, Fiorotto ML, Chin ER, and Esser KA. Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem J 380: 795-804, 2004.
25. Kolodziejczyk SM, Walsh GS, Balazsi K, Seale P, Sandoz J, Hierlihy AM, Rudnicki MA, Chamberlain JS, Miller FD, and Megeney LA. Activation of JNK1 contributes to dystrophic muscle pathogenesis. Curr Biol 11: 1278-1282, 2001.
26. Kumar A, Chaudhry I, Reid MB, and Boriek AM. Distinct signaling pathways are activated in response to mechanical stress applied axially and transversely to skeletal muscle fibers. J Biol Chem 277: 46493-46503, 2002.
27. Kumar A, Khandelwal N, Malya R, Reid MB, and Boriek AM. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 18: 102-113, 2004.
28. Kuppuswamy D. Importance of integrin signaling in myocyte growth and survival. Circ Res 90: 1240-1242, 2002.
29. Lapidos KA, Kakkar R, and McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 94: 1023-1031, 2004.
30. Martineau LC and Gardiner PF. Insight into skeletal muscle mechanotransduction: MAPK activation is quantitatively related to tension. J Appl Physiol 91: 693-702, 2001.
31. Martineau LC and Gardiner PF. Skeletal muscle is sensitive to the tension-time integral but not to the rate of change of tension, as assessed by mechanically induced signaling. J Biomech 35: 657-663, 2002.
32. McNally EM, Duggan D, Gorospe JR, Bonnemann CG, Fanin M, Pegoraro E, Lidov HG, Noguchi S, Ozawa E, Finkel RS, Cruse RP, Angelini C, Kunkel LM, and Hoffman EP. Mutations that disrupt the carboxyl-terminus of γ-sarcoglycan cause muscular dystrophy. Hum Mol Genet 5: 1841-1847, 1996.
33. McNally EM, Passos-Bueno MR, Bonnemann CG, Vainzof M, de Sa Moreira E, Lidov HG, Othmane KB, Denton PH, Vance JM, Zatz M, and Kunkel LM. Mild and severe muscular dystrophy caused by a single γ-sarcoglycan mutation. Am J Hum Genet 59: 1040-1047, 1996.
34. Ozawa E, Noguchi S, Mizuno Y, Hagiwara Y, and Yoshida M. From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve 21: 421-438, 1998.
35. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, and Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993.
36. Renshaw MW, Price LS, and Schwartz MA. Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase. J Cell Biol 147: 611-618, 1999.
37. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, and Zierath JR. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 275: 1457-1462, 2000.
38. S6K, and Akt by contraction and insulin in rat skeletal muscle. Am J Physiol Endocrinol Metab 276: E870-E878, 1999.
39. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, and Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578-1580, 1989.
40. Tatsumi R, Hattori A, Ikeuchi Y, Anderson JE, and Allen RE. Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol Biol Cell 13: 2909-2918, 2002.
41. Tatsumi R, Sheehan SM, Iwasaki H, Hattori A, and Allen RE. Mechanical stretch induces activation of skeletal muscle satellite cells in vitro. Exp Cell Res 267: 107-114, 2001.
42. Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M, and Richard I. Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol 23: 9127-9135, 2003.
43. Thompson TG, Chan YM, Hack AA, Brosius M, Rajala M, Lidov HG, McNally EM, Watkins S, and Kunkel LM. Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein. J Cell Biol 148: 115-126, 2000.
44. Vachon PH, Xu H, Liu L, Loechel F, Hayashi Y, Arahata K, Reed JC, Wewer UM, and Engvall E. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest 100: 1870-1881, 1997.
45. Wieneke S, Heimann P, Leibovitz S, Nudel U, and Jockusch H. Acute pathophysiological effects of muscle-expressed Dp71 transgene on normal and dystrophic mouse muscle. J Appl Physiol 95: 1861-1866, 2003.
46. Yoshida M, Hama H, Ishikawa-Sakurai M, Imamura M, Mizuno Y, Araishi K, Wakabayashi-Takai E, Noguchi S, Sasaoka T, and Ozawa E. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum Mol Genet 9: 1033-1040, 2000.
47. Yoshida T, Pan Y, Hanada H, Iwata Y, and Shigekawa M. Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes. J Biol Chem 273: 1583-1590, 1998.